Many medical advancements – from life-saving vaccines and treatments to new diagnostic tests like liquid biopsies – are built on research that involves human biospecimens. Biofluids, tissue and cells are indispensable resources for the medical researcher, yet the process of sourcing these biospecimens can be woefully frustrating and inefficient. These challenges can have a direct, negative impact on the pace of discovery, creating urgency for improved access to the biospecimens researchers need
Read More
Vital
Media Mix Transformation for Pharma Marketers: The Power of CTV & Digital Video
Consumers continue to cut ties with traditional TV and cable services, prompting industries like the prescription pharmaceutical industry to evolve their marketing mix to accommodate emerging media.
Pharma advertisers spend billions on traditional TV advertising, but as streaming services began to experience explosive growth early in the pandemic, advertising strategies had to adapt. TV-centric advertisers relied on (and still rely on) dayparting (scheduling ads during certain times of the
Read More
The Twin Toll of Peripheral Artery Disease and Diabetes on Minority Communities
Diabetes is one of the most common chronic diseases in the United States, with more than 34 million individuals living with the condition.
It’s hard enough to manage this condition on a daily basis — and it gets even harder with the realization that diabetes doesn’t just exist in isolation. A diabetes diagnosis immediately triggers a domino effect of higher risks for other conditions and complications, including kidney damage, eye damage, neuropathy, and cardiovascular
Read More
Executive Roundtable: Can Innovation Alleviate Clinician Burnout?
The U.S. Surgeon General’s recent advisory about clinician burnout cited numerous societal, cultural, structural, and organizational causes—including excessive workloads, administrative burden, and lack of organizational support. The potential fallout of this trajectory is alarming: The advisory cites the Association of American Medical Colleges’ estimate on clinician demand outpacing supply, with an anticipated shortage of between
Read More
Practicing for the Next Pandemic with Real-World Data
Data reporting challenges during the current pandemic relate to the lack of connectivity between public health and information technology (IT) reporting systems throughout the country. While access to real-world data (RWD) helps address this situation, the solution goes beyond simple accessibility.
Real-world data represents data collected outside of randomized clinical trials, such as patient data from electronic health records (EHRs), mobile and smart devices, claims and billing activity
Read More
COVID-19: Addressing the Urgent Mental Health Needs of Frontline Workers
It is no secret that one by-product of the ongoing pandemic is an exacerbation of the country’s mental health crisis. According to research from Johns Hopkins, one in four Americans experience a mental health disorder in a typical year. Yet among adults in the U.S. rates of depression have steadily climbed from 8.5% before the pandemic to an alarming 32.8% in October of 2021, according to research published in The Lancet Regional Health—Americas.
While it is vital that health systems rush
Read More
Innovaccer Expands into Public Sector to Accelerate Public Health Transformation
What You Should Know:
- Health cloud company Innovaccer Inc, today announced it is expanding into the public sector to improve collaboration between agencies, optimize case management, manage increasingly complex alternative payment models, and improve the individual’s experience through technology.
- The Innovaccer Health Cloud’s Data Activation Platform (DAP) collects, cleans, and connects data, making it available and shareable between systems to accelerate digital
Read More
Particle Health Raises $25M to Scale Health Data Exchange API Platform
What You Should Know:
- Particle Health, a New York-based API platform for advanced healthcare data exchange, , today announced its Series B financing of $25 million led by Canvas Ventures with participation from Menlo Ventures, Story Ventures, and Pruven Capital. The financing brings the organization’s total capital raised to $39.3M.
- From a healthcare infrastructure perspective, the company is leading the industry in applying the next-generation FHIR data format to make interoperability
Read More
Reimagining The Future of Pharmacovigilance (PV): Regulations, Tech, Public Perceptions
Monitoring the safe and effective use of medicines has now been an essential part of public health policy for several decades. New advances in technology (e.g., ICH E2B for the electronic exchange of case reports) over the past 20 years coupled with progressive legislation have been a catalyst for an explosion in safety data over this period.
Since the World Health Organization (WHO) declared the Covid-19 pandemic in March 2020, the rate of reporting of safety data has been unprecedented
Read More
Why Health Plans Are Vital to Health Equity
In Florida, where Black residents are three times more likely to be hospitalized or die from asthma-related complications than white residents, one researcher’s efforts to “strip away the jargon” related to asthma treatment strengthened patients’ engagement in a year-long clinical trial. The impact: development of an asthma regimen to help combat disparities in asthma management and outcomes.
The results are one example of the gains that can be made in addressing health inequities—differences
Read More
